Advances in ceramic-based nanocarriers for cardiovascular treatment: a comprehensive review

Journal of Chemical Sciences · Springer Nature · 2026-11-19 · DOI: 10.1007/s12257-026-00344-9

Аннотация

Cardiovascular diseases (CVDs) are one of the leading causes of death worldwide; thus, the development of new safe and effective treatment strategies is a matter of great concern. Conventional treatment approaches, such as oral, systemic, or surgical administration, are often associated with reduced bioavailability, low targeting efficacy, rapid drug degradation, cytotoxicity, or ineffective distribution throughout the body. Ceramic nanoparticles are a new class of nanostructured materials that can be used for targeted molecular therapy of CVDs with enhanced targeting capacity and versatility. The surface-modification ability of ceramic nanoparticles with various ligands, tailorable pore size, high-efficiency incorporation of different drugs, and outstanding physiological stability and biocompatibility, offer a versatile platform for developing single- and multi-targeting therapeutics, making the ceramic nanoparticles superior to many organic nanoparticles. This review discusses the design and application of various classes of ceramic nanoparticles, including hydroxyapatite and calcium phosphates, silica, layered double hydroxides, and bioactive glass, for targeted drug delivery and regenerative medicine in atherosclerosis, acute myocardial infarction, and other cardiovascular diseases. Particular attention is paid here to the importance of ceramic nanoparticle composition and to the challenges in reticuloendothelial system clearance, biosafety, scalability, circulation time, and hemocompatibility for their efficiency in vivo application. Moreover, due to their unique chemical versatility and biocompatibility, ceramic nanoparticles could serve as valuable tools for targeted treatment of CVDs.

Читать у издателя →

Похожие статьи